Product Description

This article was prepared to accompany practice-based assessment with ongoing surgical education for the Maintenance of Certification for the American Board of Plastic Surgery. It is structured to outline the care of the patient with the postmastectomy breast deformity. (Plast. Reconstr. Surg. 139:204e, 2017.)  

Learning Objectives

After viewing this course, the participant should be able to:

1. Gain an understanding of the different methods of autologous reconstruction available.
2. Understand the timing of autologous breast reconstruction and the impact of adjuvant and neoadjuvant treatments.
3. Understand the factors necessary for a comprehensive patient assessment.
4. Gain knowledge of patient factors that will affect autologous reconstruction and potential contraindications.
5. Summarize the patient-reported and clinical outcomes of autologous breast reconstruction.

Faculty

Sheina A. Macadam MD MHS; Esta S. Bovill MD PhD; Edward W. Buchel MD; Peter A. Lennox MD

Plastic and Reconstruction Surgery® Editors:

Editor-in-Chief: Rod J. Rohrich, MD 

Co-Editor: James M. Stuzin, MD 

Section Editor: Donald H. Lalonde, MD

Accreditation Information

Patient Safety Credit: 0.5 

Media: Journal Article, Video 

Publish Date: 12/28/2016

Estimated time to complete this course: 1.0 hour 

Directly provided by the American Society of Plastic Surgeons^® (ASPS^®)

Accreditation Statement

The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Intended Audience

This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.

Disclosures

Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.

Product Code: 20907